IBDEI0AW ; ; 20-FEB-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 20, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,14471,0)
 ;;=V13.4^^107^874^47
 ;;^UTILITY(U,$J,358.3,14471,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14471,1,4,0)
 ;;=4^V13.4
 ;;^UTILITY(U,$J,358.3,14471,1,5,0)
 ;;=5^Personal H/O Arthritis
 ;;^UTILITY(U,$J,358.3,14471,2)
 ;;=^295267
 ;;^UTILITY(U,$J,358.3,14472,0)
 ;;=V12.72^^107^874^48
 ;;^UTILITY(U,$J,358.3,14472,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14472,1,4,0)
 ;;=4^V12.72
 ;;^UTILITY(U,$J,358.3,14472,1,5,0)
 ;;=5^Personal H/O Colon Polyps
 ;;^UTILITY(U,$J,358.3,14472,2)
 ;;=^303401
 ;;^UTILITY(U,$J,358.3,14473,0)
 ;;=V12.59^^107^874^49
 ;;^UTILITY(U,$J,358.3,14473,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14473,1,4,0)
 ;;=4^V12.59
 ;;^UTILITY(U,$J,358.3,14473,1,5,0)
 ;;=5^Personal H/O Congestive Heart Failure
 ;;^UTILITY(U,$J,358.3,14473,2)
 ;;=^303399
 ;;^UTILITY(U,$J,358.3,14474,0)
 ;;=V45.81^^107^874^50
 ;;^UTILITY(U,$J,358.3,14474,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14474,1,4,0)
 ;;=4^V45.81
 ;;^UTILITY(U,$J,358.3,14474,1,5,0)
 ;;=5^Personal H/O Coronary Bypass
 ;;^UTILITY(U,$J,358.3,14474,2)
 ;;=^97129
 ;;^UTILITY(U,$J,358.3,14475,0)
 ;;=V15.84^^107^874^51
 ;;^UTILITY(U,$J,358.3,14475,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14475,1,4,0)
 ;;=4^V15.84
 ;;^UTILITY(U,$J,358.3,14475,1,5,0)
 ;;=5^Personal H/O Exposure To Asbestos
 ;;^UTILITY(U,$J,358.3,14475,2)
 ;;=^303406
 ;;^UTILITY(U,$J,358.3,14476,0)
 ;;=V15.85^^107^874^57
 ;;^UTILITY(U,$J,358.3,14476,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14476,1,4,0)
 ;;=4^V15.85
 ;;^UTILITY(U,$J,358.3,14476,1,5,0)
 ;;=5^Personal H/O Potentially Hazardous Body Fluids
 ;;^UTILITY(U,$J,358.3,14476,2)
 ;;=^303407
 ;;^UTILITY(U,$J,358.3,14477,0)
 ;;=V10.72^^107^874^53
 ;;^UTILITY(U,$J,358.3,14477,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14477,1,4,0)
 ;;=4^V10.72
 ;;^UTILITY(U,$J,358.3,14477,1,5,0)
 ;;=5^Personal H/O Hodgkin'S Disease
 ;;^UTILITY(U,$J,358.3,14477,2)
 ;;=^295237
 ;;^UTILITY(U,$J,358.3,14478,0)
 ;;=V15.3^^107^874^54
 ;;^UTILITY(U,$J,358.3,14478,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14478,1,4,0)
 ;;=4^V15.3
 ;;^UTILITY(U,$J,358.3,14478,1,5,0)
 ;;=5^Personal H/O Irradiation
 ;;^UTILITY(U,$J,358.3,14478,2)
 ;;=^295285
 ;;^UTILITY(U,$J,358.3,14479,0)
 ;;=V10.61^^107^874^29
 ;;^UTILITY(U,$J,358.3,14479,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14479,1,4,0)
 ;;=4^V10.61
 ;;^UTILITY(U,$J,358.3,14479,1,5,0)
 ;;=5^Hx Of Lymphoid Leukemia
 ;;^UTILITY(U,$J,358.3,14479,2)
 ;;=Hx of Lymphoid Leukemia^295232
 ;;^UTILITY(U,$J,358.3,14480,0)
 ;;=V12.03^^107^874^30
 ;;^UTILITY(U,$J,358.3,14480,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14480,1,4,0)
 ;;=4^V12.03
 ;;^UTILITY(U,$J,358.3,14480,1,5,0)
 ;;=5^Hx Of Malaria
 ;;^UTILITY(U,$J,358.3,14480,2)
 ;;=Hx of Malaria^303395
 ;;^UTILITY(U,$J,358.3,14481,0)
 ;;=V10.82^^107^874^31
 ;;^UTILITY(U,$J,358.3,14481,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14481,1,4,0)
 ;;=4^V10.82
 ;;^UTILITY(U,$J,358.3,14481,1,5,0)
 ;;=5^Hx Of Malignant Melanoma
 ;;^UTILITY(U,$J,358.3,14481,2)
 ;;=Hx of Malignant Melanoma^295240
 ;;^UTILITY(U,$J,358.3,14482,0)
 ;;=V10.62^^107^874^33
 ;;^UTILITY(U,$J,358.3,14482,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14482,1,4,0)
 ;;=4^V10.62
 ;;^UTILITY(U,$J,358.3,14482,1,5,0)
 ;;=5^Hx Of Myeloid Leukemia
 ;;^UTILITY(U,$J,358.3,14482,2)
 ;;=Hx of Myeloid Leukemia^295233
 ;;^UTILITY(U,$J,358.3,14483,0)
 ;;=V10.63^^107^874^32
 ;;^UTILITY(U,$J,358.3,14483,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14483,1,4,0)
 ;;=4^V10.63
 ;;^UTILITY(U,$J,358.3,14483,1,5,0)
 ;;=5^Hx Of Monocytic Leukemia
 ;;^UTILITY(U,$J,358.3,14483,2)
 ;;=Hx of Monocytic Leukemia^295234
 ;;^UTILITY(U,$J,358.3,14484,0)
 ;;=V11.2^^107^874^27
 ;;^UTILITY(U,$J,358.3,14484,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14484,1,4,0)
 ;;=4^V11.2
 ;;^UTILITY(U,$J,358.3,14484,1,5,0)
 ;;=5^Hx Of Dysthymia
 ;;^UTILITY(U,$J,358.3,14484,2)
 ;;=Hx of Dysthymia^295251
 ;;^UTILITY(U,$J,358.3,14485,0)
 ;;=V15.81^^107^874^43
 ;;^UTILITY(U,$J,358.3,14485,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14485,1,4,0)
 ;;=4^V15.81
 ;;^UTILITY(U,$J,358.3,14485,1,5,0)
 ;;=5^Noncompliance With Medical Treatment
 ;;^UTILITY(U,$J,358.3,14485,2)
 ;;=^295290
 ;;^UTILITY(U,$J,358.3,14486,0)
 ;;=V10.43^^107^874^34
 ;;^UTILITY(U,$J,358.3,14486,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14486,1,4,0)
 ;;=4^V10.43
 ;;^UTILITY(U,$J,358.3,14486,1,5,0)
 ;;=5^Hx Of Ovarian Ca
 ;;^UTILITY(U,$J,358.3,14486,2)
 ;;=Hx of Ovarian CA^295221
 ;;^UTILITY(U,$J,358.3,14487,0)
 ;;=V12.71^^107^874^35
 ;;^UTILITY(U,$J,358.3,14487,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14487,1,4,0)
 ;;=4^V12.71
 ;;^UTILITY(U,$J,358.3,14487,1,5,0)
 ;;=5^Hx Of Peptic Ulcer Disease
 ;;^UTILITY(U,$J,358.3,14487,2)
 ;;=^303400
 ;;^UTILITY(U,$J,358.3,14488,0)
 ;;=V10.46^^107^874^36
 ;;^UTILITY(U,$J,358.3,14488,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14488,1,4,0)
 ;;=4^V10.46
 ;;^UTILITY(U,$J,358.3,14488,1,5,0)
 ;;=5^Hx Of Prostate Cancer
 ;;^UTILITY(U,$J,358.3,14488,2)
 ;;=Hx of Prostate Cancer^295224
 ;;^UTILITY(U,$J,358.3,14489,0)
 ;;=V11.0^^107^874^37
 ;;^UTILITY(U,$J,358.3,14489,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14489,1,4,0)
 ;;=4^V11.0
 ;;^UTILITY(U,$J,358.3,14489,1,5,0)
 ;;=5^Hx Of Schizophrenia
 ;;^UTILITY(U,$J,358.3,14489,2)
 ;;=Hx of Schizophrenia^295249
 ;;^UTILITY(U,$J,358.3,14490,0)
 ;;=V10.83^^107^874^38
 ;;^UTILITY(U,$J,358.3,14490,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14490,1,4,0)
 ;;=4^V10.83
 ;;^UTILITY(U,$J,358.3,14490,1,5,0)
 ;;=5^Hx Of Skin Cancer (Non-Melanoma)
 ;;^UTILITY(U,$J,358.3,14490,2)
 ;;=^295241
 ;;^UTILITY(U,$J,358.3,14491,0)
 ;;=V15.1^^107^874^39
 ;;^UTILITY(U,$J,358.3,14491,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14491,1,4,0)
 ;;=4^V15.1
 ;;^UTILITY(U,$J,358.3,14491,1,5,0)
 ;;=5^Hx Of Surgery To Heart And Great Vessels
 ;;^UTILITY(U,$J,358.3,14491,2)
 ;;=^295283
 ;;^UTILITY(U,$J,358.3,14492,0)
 ;;=V15.82^^107^874^41
 ;;^UTILITY(U,$J,358.3,14492,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14492,1,4,0)
 ;;=4^V15.82
 ;;^UTILITY(U,$J,358.3,14492,1,5,0)
 ;;=5^Hx Of Tobacco Use (Not Current)
 ;;^UTILITY(U,$J,358.3,14492,2)
 ;;=Hx of Tobacco Use (not current)^303405
 ;;^UTILITY(U,$J,358.3,14493,0)
 ;;=V12.01^^107^874^40
 ;;^UTILITY(U,$J,358.3,14493,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14493,1,4,0)
 ;;=4^V12.01
 ;;^UTILITY(U,$J,358.3,14493,1,5,0)
 ;;=5^Hx of TB
 ;;^UTILITY(U,$J,358.3,14493,2)
 ;;=Hx of TB^303393
 ;;^UTILITY(U,$J,358.3,14494,0)
 ;;=V13.01^^107^874^28
 ;;^UTILITY(U,$J,358.3,14494,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14494,1,4,0)
 ;;=4^V13.01
 ;;^UTILITY(U,$J,358.3,14494,1,5,0)
 ;;=5^Hx Of Kidney Stones
 ;;^UTILITY(U,$J,358.3,14494,2)
 ;;=Hx of Kidney Stones^303403
 ;;^UTILITY(U,$J,358.3,14495,0)
 ;;=V12.51^^107^874^42
 ;;^UTILITY(U,$J,358.3,14495,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14495,1,4,0)
 ;;=4^V12.51
 ;;^UTILITY(U,$J,358.3,14495,1,5,0)
 ;;=5^Hx Of Venous Thrombosis And Embolism
 ;;^UTILITY(U,$J,358.3,14495,2)
 ;;=^303397
 ;;^UTILITY(U,$J,358.3,14496,0)
 ;;=V17.89^^107^874^1
 ;;^UTILITY(U,$J,358.3,14496,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14496,1,4,0)
 ;;=4^V17.89
 ;;^UTILITY(U,$J,358.3,14496,1,5,0)
 ;;=5^Fam Hx Musculosk Dis
 ;;^UTILITY(U,$J,358.3,14496,2)
 ;;=^332861
 ;;^UTILITY(U,$J,358.3,14497,0)
 ;;=V12.54^^107^874^26
 ;;^UTILITY(U,$J,358.3,14497,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14497,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,14497,1,5,0)
 ;;=5^HX of TIA
 ;;^UTILITY(U,$J,358.3,14497,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,14498,0)
 ;;=V12.54^^107^874^25
 ;;^UTILITY(U,$J,358.3,14498,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14498,1,4,0)
 ;;=4^V12.54
 ;;^UTILITY(U,$J,358.3,14498,1,5,0)
 ;;=5^HX of Stroke w/o Residuals
 ;;^UTILITY(U,$J,358.3,14498,2)
 ;;=^335309
 ;;^UTILITY(U,$J,358.3,14499,0)
 ;;=V15.88^^107^874^23
 ;;^UTILITY(U,$J,358.3,14499,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14499,1,4,0)
 ;;=4^V15.88
 ;;^UTILITY(U,$J,358.3,14499,1,5,0)
 ;;=5^HX of Falls
 ;;^UTILITY(U,$J,358.3,14499,2)
 ;;=^332859
 ;;^UTILITY(U,$J,358.3,14500,0)
 ;;=V13.59^^107^874^24
 ;;^UTILITY(U,$J,358.3,14500,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14500,1,4,0)
 ;;=4^V13.59
 ;;^UTILITY(U,$J,358.3,14500,1,5,0)
 ;;=5^HX of Musculoskletl Dis NEC
 ;;^UTILITY(U,$J,358.3,14500,2)
 ;;=^295268
 ;;^UTILITY(U,$J,358.3,14501,0)
 ;;=V12.04^^107^874^55
 ;;^UTILITY(U,$J,358.3,14501,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14501,1,4,0)
 ;;=4^V12.04
 ;;^UTILITY(U,$J,358.3,14501,1,5,0)
 ;;=5^Personal H/O MRSA infection
 ;;^UTILITY(U,$J,358.3,14501,2)
 ;;=^336780
 ;;^UTILITY(U,$J,358.3,14502,0)
 ;;=V62.22^^107^874^58
 ;;^UTILITY(U,$J,358.3,14502,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14502,1,4,0)
 ;;=4^V62.22
 ;;^UTILITY(U,$J,358.3,14502,1,5,0)
 ;;=5^Personal H/O Retrn Military Deploy
 ;;^UTILITY(U,$J,358.3,14502,2)
 ;;=^336807
 ;;^UTILITY(U,$J,358.3,14503,0)
 ;;=V13.51^^107^874^56
 ;;^UTILITY(U,$J,358.3,14503,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14503,1,4,0)
 ;;=4^V13.51
 ;;^UTILITY(U,$J,358.3,14503,1,5,0)
 ;;=5^Personal H/O Pathological FX
 ;;^UTILITY(U,$J,358.3,14503,2)
 ;;=^336781
 ;;^UTILITY(U,$J,358.3,14504,0)
 ;;=V15.51^^107^874^60
 ;;^UTILITY(U,$J,358.3,14504,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14504,1,4,0)
 ;;=4^V15.51
 ;;^UTILITY(U,$J,358.3,14504,1,5,0)
 ;;=5^Personal H/O Traumatic FX
 ;;^UTILITY(U,$J,358.3,14504,2)
 ;;=^336786
 ;;^UTILITY(U,$J,358.3,14505,0)
 ;;=V15.52^^107^874^59
 ;;^UTILITY(U,$J,358.3,14505,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14505,1,4,0)
 ;;=4^V15.52
 ;;^UTILITY(U,$J,358.3,14505,1,5,0)
 ;;=5^Personal H/O Traumatic Brain Injury
 ;;^UTILITY(U,$J,358.3,14505,2)
 ;;=^338495
 ;;^UTILITY(U,$J,358.3,14506,0)
 ;;=V70.0^^107^875^1
 ;;^UTILITY(U,$J,358.3,14506,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,14506,1,4,0)
 ;;=4^V70.0
 ;;^UTILITY(U,$J,358.3,14506,1,5,0)
 ;;=5^Routine Med Exam
